pamrevlumab (FG-3019)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for pamrevlumab (FG-3019), covering 2019-02-22 to 2021-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) [Phase 2]